BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37403010)

  • 1. The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males.
    Morena da Silva F; Lim S; Cabrera AR; Schrems ER; Jones RG; Rosa-Caldwell ME; Washington TA; Murach KA; Greene NP
    BMC Genomics; 2023 Jul; 24(1):374. PubMed ID: 37403010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.
    Blackwell TA; Cervenka I; Khatri B; Brown JL; Rosa-Caldwell ME; Lee DE; Perry RA; Brown LA; Haynie WS; Wiggs MP; Bottje WG; Washington TA; Kong BC; Ruas JL; Greene NP
    Physiol Genomics; 2018 Dec; 50(12):1071-1082. PubMed ID: 30289747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia.
    Cabrera AR; Deaver JW; Lim S; Morena da Silva F; Schrems ER; Saling LW; Tsitkanou S; Rosa-Caldwell ME; Wiggs MP; Washington TA; Greene NP
    J Appl Physiol (1985); 2023 Sep; 135(3):655-672. PubMed ID: 37535708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.
    Cardaci TD; VanderVeen BN; Bullard BM; McDonald SJ; Unger CA; Enos RT; Fan D; Velázquez KT; Frizzell N; Spangenburg EE; Murphy EA
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):124-137. PubMed ID: 38062911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of metabolic and contractile alterations in development of cancer cachexia in female tumor-bearing mice.
    Lim S; Deaver JW; Rosa-Caldwell ME; Haynie WS; Morena da Silva F; Cabrera AR; Schrems ER; Saling LW; Jansen LT; Dunlap KR; Wiggs MP; Washington TA; Greene NP
    J Appl Physiol (1985); 2022 Jan; 132(1):58-72. PubMed ID: 34762526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice.
    Morena da Silva F; Rosa-Caldwell ME; Schrems ER; Martinez L; Amos MG; Lim S; Cabrera AR; Brown JL; Washington TA; Greene NP
    Appl Physiol Nutr Metab; 2022 Sep; 47(9):933-948. PubMed ID: 35700525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
    Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
    Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REDD1 deletion attenuates cancer cachexia in mice.
    Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL
    J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
    Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
    Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
    Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
    Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
    Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
    Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of skeletal muscle fibrosis in a rodent model of cancer cachexia.
    Washington TA; Schrems ER; Haynie WS; Rosa-Caldwell ME; Brown JL; Saling L; Lim S; Perry RA; Brown LA; Lee DE; Greene NP
    Cell Biochem Funct; 2023 Jun; 41(4):478-489. PubMed ID: 37150891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia.
    Wang X; Pickrell AM; Zimmers TA; Moraes CT
    PLoS One; 2012; 7(3):e33426. PubMed ID: 22428048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
    Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
    Li Y; Zhang F; Modrak S; Little A; Zhang H
    Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.